Testing effectiveness (Phase 2)Study completedNCT03108131
What this trial is testing
Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors
Who this might be right for
Skin Squamous Cell CarcinomaAppendix AdenocarcinomaRare Lesion+9 more
M.D. Anderson Cancer Center 49